Hospital @ Home Model of Care for Cirrhosis
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.
Sponsor: Indiana University
You may qualify if…
- ✓ Enrolled into IUH's H@H program
- ✓ At least 18 years of age
- ✓ Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
- ✓ English speaking
- ✓ Able to provide consent
- ✓ Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
- ✓ Able to perform activities of daily living independently
- ✓ Lives within IU Health Home service area
You may not qualify if…
- ✕ Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
- ✕ Transplant of organ other than liver
- ✕ Pregnant
- ✕ Incarcerated
- ✕ New hemodialysis
- ✕ Blood pressure \< 90/60, Pulse \> 120, O2 \> 6L or \>2L above baseline
- ✕ HIV+/CD4 count \< 200
- ✕ Receiving hospice services
Where it's recruiting
Indianapolis
Source: ClinicalTrials.gov · NCT06396897 · last updated 2025-08-19